Skip to Main Content

Paper Details

Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF: From the GUIDE-IT Trial.
JACC Heart Fail
24
2022
38-variable deficit, HF, HFrEF, Heart Failure, Patients, angiotensin receptor, angiotensin-converting enzyme, frailty, heart failure, mineralocorticoid receptor, participants, patients
Author NameAffiliation
Matthew W SegarTexas Heart Institute
Gregg C FonarowRonald Reagan-university of california los angeles Medical Center
Gregg C FonarowRonald Reagan-university of california los angeles Medical Center
Gary Michael FelkerDuke University School of Medicine, USA Duke Clinical Research Institute
  • 1 - 4

Datasets

Release 1.2